106 related articles for article (PubMed ID: 9482168)
21. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man.
Chiabrando C; Rivoltella L; Alberti E; Bonollo M; Djurup R; Fanelli R
Prostaglandins; 1993 May; 45(5):401-11. PubMed ID: 8321910
[TBL] [Abstract][Full Text] [Related]
22. Improved assay for the quantification of 11-dehydrothromboxane B2 by gas chromatography-mass spectrometry.
Morrow JD; Minton TA
J Chromatogr; 1993 Feb; 612(2):179-85. PubMed ID: 8468374
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the major urinary thromboxane metabolites, 2,3-dinorthromboxane B2 and 11-dehydrothromboxane B2, by gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry.
Uedelhoven WM; Meese CO; Weber PC
J Chromatogr; 1989 Dec; 497():1-16. PubMed ID: 2625446
[TBL] [Abstract][Full Text] [Related]
24. Urinary 11-Dehydro-Thromboxane B2 as a Predictor of Acute Myocardial Infarction Outcomes: Results of Leukotrienes and Thromboxane In Myocardial Infarction (LTIMI) Study.
Szczeklik W; Stodółkiewicz E; Rzeszutko M; Tomala M; Chrustowicz A; Żmudka K; Sanak M
J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27481134
[TBL] [Abstract][Full Text] [Related]
25. [Urinary 11-dehydro thromboxane B2 during toxemic pregnancies].
Kobayashi S
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):715-21. PubMed ID: 1890349
[TBL] [Abstract][Full Text] [Related]
26. Immunoaffinity purification of 11-dehydro-thromboxane B2 from human urine and plasma for quantitative analysis by radioimmunoassay.
Hayashi Y; Shono F; Yamamoto S; Takasaki W; Nakagawa A; Watanabe K; Yamashita K; Miyazaki H
Anal Biochem; 1990 May; 187(1):151-9. PubMed ID: 2372112
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia.
Cangemi R; Carnevale R; Nocella C; Calvieri C; Cammisotto V; Novo M; Castellani V; D'Amico A; Zerbinati C; Stefanini L; Violi F;
Pharmacol Res; 2018 May; 131():66-74. PubMed ID: 29577968
[TBL] [Abstract][Full Text] [Related]
28. Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis.
Nakamura H; Hishinuma T; Suzuki N; Chiba S; Tsukamoto H; Takabatake M; Sawai T; Mitomo T; Inoue H; Matsumoto F; Mizugaki M
Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):301-6. PubMed ID: 11993724
[TBL] [Abstract][Full Text] [Related]
29. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
[TBL] [Abstract][Full Text] [Related]
30. A new method using simple solid phase extraction for the rapid gas-chromatographic mass-spectrometric determination of 11-dehydro-thromboxane B2 in urine.
Lorenz R; Helmer P; Uedelhoven W; Zimmer B; Weber PC
Prostaglandins; 1989 Aug; 38(2):157-70. PubMed ID: 2772221
[TBL] [Abstract][Full Text] [Related]
31. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
[TBL] [Abstract][Full Text] [Related]
32. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R
J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794
[TBL] [Abstract][Full Text] [Related]
33. 11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs.
Yamanaka S; Miura K; Yukimura T; Yamamoto K
Prostaglandins; 1993 Mar; 45(3):221-8. PubMed ID: 8484010
[TBL] [Abstract][Full Text] [Related]
34. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence.
Lin JS; Lui SM; Chen CM; Chang WC
J Urol; 1992 Aug; 148(2 Pt 1):311-3. PubMed ID: 1635125
[TBL] [Abstract][Full Text] [Related]
35. GC/MS/MS quantification of 11-dehydrothromboxane B2 in human urine.
Ferretti A; Flanagan VP; Maida EJ
Prostaglandins Leukot Essent Fatty Acids; 1992 Aug; 46(4):271-5. PubMed ID: 1409763
[TBL] [Abstract][Full Text] [Related]
36. Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain.
Foegh ML; Zhao Y; Madren L; Rolnick M; Stair TO; Huang KS; Ramwell PW
J Intern Med; 1994 Feb; 235(2):153-61. PubMed ID: 8308478
[TBL] [Abstract][Full Text] [Related]
37. In retinal vein occlusion platelet response to thrombin is increased.
Leoncini G; Signorello MG; Segantin A; Giacobbe E; Armani U; Piana A; Camicione P
Thromb Res; 2009 Dec; 124(6):e48-55. PubMed ID: 19660790
[TBL] [Abstract][Full Text] [Related]
38. Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Cangemi R; Hiatt WR; Bartimoccia S; Nocella C; Vicario T; Bucci T; Carnevale R; Lip GY; Violi F
Am Heart J; 2015 Sep; 170(3):490-7.e1. PubMed ID: 26385032
[TBL] [Abstract][Full Text] [Related]
39. A chemiluminescent immunoassay for urinary thromboxane B2.
Morello A; Chang S; Jacob A; Law SJ; Stastny M; Martin L; Pamidi A; Kotake A
Prostaglandins; 1991 Jul; 42(1):55-70. PubMed ID: 1771240
[TBL] [Abstract][Full Text] [Related]
40. Development of a GC-MS method for quantitation of 2,3-dinor-TxB2 and determinations of the daily urinary excretion rates in healthy humans.
Vesterqvist O; Gréen K; Lincoln FH; Sebek OK
Thromb Res; 1984 Jan; 33(1):39-49. PubMed ID: 6695361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
